Aduro BioTech Obtains $119,000,000 New Funding

  • Feed Type
  • Date
    4/15/2015
  • Company Name
    Aduro BioTech
  • Mailing Address
    626 Bancroft Way Berkeley, CA 94710 USA
  • Company Description
    Aduro BioTech (NASDAQ: ADRO) is an immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases.
  • Website
    http://www.adurobiotech.com
  • Transaction Type
    IPO
  • Transaction Amount
    $119,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy